{
    "2019-04-03": [
        [
            {
                "time": "2019-04-03",
                "original_text": "Health Care Sector Update for 04/03/2019: EVGN, ADXS, ACHN, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "PFE",
                        "MRK"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "Sangamo Rises on Positive Phase I/II Hemophilia Study Data",
                "features": {
                    "keywords": [
                        "Sangamo",
                        "Positive",
                        "Phase I/II",
                        "Hemophilia",
                        "Study Data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "Why the Earnings Surprise Streak Could Continue for Pfizer (PFE)",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Surprise",
                        "Streak",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "Does Sangamo Have the Best Gene Therapy Program Now?",
                "features": {
                    "keywords": [
                        "Sangamo",
                        "Gene Therapy",
                        "Program"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "VIZIMPROÂ® (dacomitinib) Receives Marketing Authorization in European Union (EU) for the First-Line Treatment of Adult Patients with EGFR-Mutated Non-Small Cell Lung Cancer",
                "features": {
                    "keywords": [
                        "VIZIMPRO",
                        "Marketing Authorization",
                        "EU",
                        "EGFR-Mutated",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 04, 2019",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Ex-Dividend",
                        "Date"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "3 Big Stock Charts for Wednesday: Twitter, Western Union and Wynn Resorts",
                "features": {
                    "keywords": [
                        "Stock Charts",
                        "Twitter",
                        "Western Union",
                        "Wynn Resorts"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "financial services",
                        "hospitality"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-03",
                "original_text": "Micron Technology, Tencent and two dozen other companies most likely to benefit from a China trade deal",
                "features": {
                    "keywords": [
                        "Micron Technology",
                        "Tencent",
                        "China trade deal"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "semiconductors",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}